HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

483.155

-13.603-2.74%

Number of Gainers:7

Number of Losers:23

Number of Flat:3

PE:- -

High:496.758

Open:496.758

Low:480.328

Close:496.758

Volume:115.32M

Turnover:2.61B

Market Cap:306.93B

Float Cap:273.30B

Loading ...

Ocumension Completes First Patient Enrollment in Phase III China Trial of Dry Eye Drug OT-202

China's So-Young Q2 Revenue Rises, Net Loss Narrows

China's Rainmed Medical H1 Revenue Rises, Net Loss Narrows

Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales

Lee's Pharm Reports 41.4% Profit Surge in H1 Results

China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth

Shanghai HeartCare Medical Technology - Board Did not Declare the Payment of an Interim Dividend

THOMSON REUTERS

Shanghai HeartCare H1 FY26 Profit Climbs 18.5% to RMB 60.37 Million; Revenue Rises 56.9% to RMB 291.03 Million

Shanghai HeartCare Medical Technology H1 Revenue RMB 291 Million

THOMSON REUTERS

Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate

AH Share Premium Report: August 31 Market Close

Ascletis Pharma Starts Phase III Trial of Weight-Loss Drug; Shares Plummet 5%

MT Newswires Live

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply

Akeso, Inc. (HKG:9926) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Simply Wall St.

Healthcare Sector Sees Continued Positive Signals; CCB Fund Manager Liang Furui Highlights High-Prosperity Areas Such as Innovative Drugs

Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses

Simply Wall St.

Ascletis Announces First Participant Dosed in a Global Phase Iii Clinical Program of Once-Daily Oral Small Molecule Glp-1 Receptor Agonist Asc30 for Chronic Weight Management

THOMSON REUTERS

Ascletis Pharma - Topline Phase Iii Data Expected Q3 2028; FDA Nda by End 2028; Ema Maa Early 2029

THOMSON REUTERS

Three New Share Subscriptions Next Week Spanning AI Chip and Innovative Drug Hotspots; Nine IPOs This Year Have Already Delivered Over 100,000 Yuan Profit Per Lot

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK1574/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":483.15506,"timestamp":1789114133774,"preClose":496.75812,"halted":0,"volume":115323363,"delay":0,"changeRate":-0.027384,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-13.603058,"latestTime":"09-11 16:00:00","open":496.75812,"high":496.75812,"low":480.32812,"amount":2611810568,"amplitude":0.033074,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":3.703217,"peRate":164.740195,"turnoverRate":0.004215,"increases":6,"decrements":25,"flats":1,"marketCap":306930068880,"floatMarketCap":273297591592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":496.75812,"amplitude":0.033074,"preClose":496.75812,"low":480.32812,"pbRate":"3.703217","latestPrice":483.15506,"volume":115323363,"delay":0,"open":496.75812,"prevYearClose":556.26263,"prevWeekClose":532.025,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":532.025,"twentyDayClose":518.327,"sixtyDayClose":434.471,"secType":"PLATE","market":"HK","turnoverRate":0.004215,"peRate":164.740195,"marketCap":306930068880,"floatMarketCap":273297591592,"timestamp":1789114133774,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":7,"down":23,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663074131","title":"Ocumension Completes First Patient Enrollment in Phase III China Trial of Dry Eye Drug OT-202","url":"https://stock-news.laohu8.com/highlight/detail?id=2663074131","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663074131?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:25","pubTimestamp":1788171922,"startTime":"0","endTime":"0","summary":"Ocumension completes first patient enrollment in Phase III China trial of dry eye drug OT-202Ocumension Therapeutics completed first patient enrollment in a China Phase III trial of OT-202 for moderat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL64Bjf6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663878074","title":"China's So-Young Q2 Revenue Rises, Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2663878074","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663878074?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:11","pubTimestamp":1788171110,"startTime":"0","endTime":"0","summary":"China's So-Young Q2 revenue rises, net loss narrowsOverviewChina aesthetic treatment platform's Q2 revenue rose 33% yr/yr, driven by branded center expansionNet loss for Q2 narrowed yr/yr, reflecting ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0BC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4563","BK1574","06609","BK1587","SY","BK4077","BK4503","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663071777","title":"China's Rainmed Medical H1 Revenue Rises, Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2663071777","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663071777?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:08","pubTimestamp":1788170928,"startTime":"0","endTime":"0","summary":"China's Rainmed Medical H1 revenue rises, net loss narrowsOverviewChina medical device maker's H1 revenue rose 41% yr/yr, driven by caFFR system salesNet loss attributable to shareholders narrowed to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0BA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","06609","BK1191","01228","BK1587","BK1100","01477","02297"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663437071","title":"Hong Kong's Lee's Pharmaceutical H1 Profit Jumps on Higher-Margin Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2663437071","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663437071?lang=en_us&edition=fundamental","pubTime":"2026-08-31 18:00","pubTimestamp":1788170409,"startTime":"0","endTime":"0","summary":"Hong Kong's Lee's Pharmaceutical H1 profit jumps on higher-margin product salesOverviewHong Kong pharma maker's interim revenue grew 14.6% yr/yr for six months ended June 2026Net income attributable t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S0AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1606","BK1583","BK1515","06622","01477","BK1587","00570","BK1191","BK1574","00950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121505356","title":"Lee's Pharm Reports 41.4% Profit Surge in H1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1121505356","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121505356?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:54","pubTimestamp":1788170056,"startTime":"0","endTime":"0","summary":"LEE'S PHARM (00950) has announced its interim results for 2026, posting a revenue of approximately HK$797 million, marking a year-on-year increase of 14.6%.The company recorded a profit attributable...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00950","BK1191","06622","BK1587","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663928076","title":"China's HeartCare Medical H1 Revenue Surges on Stroke Segment Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2663928076","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663928076?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:14","pubTimestamp":1788167685,"startTime":"0","endTime":"0","summary":"China's HeartCare Medical H1 revenue surges on stroke segment growthOverviewChina medical device maker's H1 revenue rose 56.9% yr/yr to RMB291 mlnNet profit attributable to shareholders grew 18.5% yr/","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S09G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","BK0097","BK1191","01477","600085","BK0028","BK1587","06609","BK0239","BK0183","BK0012","BK1606","06622","BK1100","01666","BK1574","BK0196","LU1688375341.USD","BK1515","BK0113","BK1583","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663763580","title":"Shanghai HeartCare Medical Technology - Board Did not Declare the Payment of an Interim Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2663763580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663763580?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166975,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R07R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06609","BK1587","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076351","title":"Shanghai HeartCare H1 FY26 Profit Climbs 18.5% to RMB 60.37 Million; Revenue Rises 56.9% to RMB 291.03 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076351","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076351?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166937,"startTime":"0","endTime":"0","summary":"Shanghai HeartCare H1 FY26 profit climbs 18.5% to RMB 60.37 million; revenue rises 56.9% to RMB 291.03 millionShanghai HeartCare posted revenue of RMB 291.03 million, up 56.9% year over year; profit a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDL636RtR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1100","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663076331","title":"Shanghai HeartCare Medical Technology H1 Revenue RMB 291 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663076331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663076331?lang=en_us&edition=fundamental","pubTime":"2026-08-31 17:02","pubTimestamp":1788166936,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nPLXBXPQPP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1100","BK1587","BK1574","06609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115184678","title":"Guangdong Hybribio Biotech's Subsidiary Secures In Vitro Diagnostic Device Registration Certificate","url":"https://stock-news.laohu8.com/highlight/detail?id=1115184678","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115184678?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:40","pubTimestamp":1788165635,"startTime":"0","endTime":"0","summary":"Guangdong Hybribio Biotech Co., Ltd. (300639.SZ) announced that its wholly-owned subsidiary, Chaozhou Kaipu Bio-Chemistry Co., Ltd. (referred to as \"Kaipu Chemistry\"), has recently obtained the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","AGNG","BK0132","BK1100","BK1574","159883","MDEV","HART","BK0046","RSPH","BK0042","MEDX","300639","PTH","09996","BK0239","LNGR","BK1583","GDOC","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102447356","title":"AH Share Premium Report: August 31 Market Close","url":"https://stock-news.laohu8.com/highlight/detail?id=1102447356","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102447356?lang=en_us&edition=fundamental","pubTime":"2026-08-31 16:21","pubTimestamp":1788164495,"startTime":"0","endTime":"0","summary":"As of the close on August 31, data shows NE ELECTRIC (00042), ZHEJIANG SHIBAO (01057), and HOLLY FUTURES (03678) hold the top three positions in the A-H share premium ranking, with premium rates of...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00991","LU2279701549.SGD","LU1328277881.USD","LU1152091754.HKD","LU1303224171.USD","LU0648948544.HKD","SG9999001226.SGD","06185","IE00B031HY20.USD","BK1144","01349","LU0589944569.HKD","03308","BK1614","LU1282649810.SGD","02827","SG9999002828.SGD","LU1119993845.HKD","SG9999002463.SGD","06690","IE00B031J352.USD","BK1576","LU0791591158.USD","LU0449509016.USD","LU0163747925.USD","LU0417516738.SGD","LU0877626530.USD","LU0890818403.SGD","LU1242518857.USD","BK1533","LU2039709279.SGD","BK1526","BK1583","00187","LU1023057109.AUD","09981","LU0254981946.USD","00300","LU0149534421.HKD","BK1237","LU0359202008.SGD","LU2476274308.USD","LU0868486357.SGD","LU2048586759.USD","00981","BK1141","LU0244354667.USD","LU1282649141.HKD","BK1202","LU2294711473.HKD","IE0034224299.USD","02218","LU0307460666.USD","BK1594","BK1562","LU0205439572.USD","IE00BF5LJ272.USD","IE00BVYPNQ40.USD","LU0327786744.USD","LU1366334651.USD","SG9999011746.SGD","BK1505","LU0918141887.USD","00042","LU0370786039.SGD","LU1152091168.USD","03188","LU1211504680.USD","BK1506","LU1880383440.USD","399300","BK1147","LU0359201612.USD","LU0456846285.SGD","LU1008478684.HKD","03268","BK1507","LU1808992512.USD","LU0128522157.USD","01033","BK1223","01057","BK1560","LU2476274720.SGD","LU0607220059.USD","03200","LU1244550494.USD","03750","LU0072913022.USD","LU0516422952.EUR","LU1688375341.USD","LU0456827905.SGD","LU2394011477.USD","03130","LU0384037296.USD","LU2125910500.SGD","83188","LU0348827113.USD","BK1149","IE00B543WZ88.USD","LU0823426480.USD","BK1514","IE00B0169L03.USD","BK1171","LU0501845795.SGD","LU0672654166.SGD","LU0320764755.SGD","LU1244550577.SGD","BK1170","LU0348805143.USD","BK1161","LU1770034418.SGD","LU0561508036.HKD","LU1880383366.USD","LU2778985437.USD","03296","HK0001040168.HKD","LU0164880469.USD","159982","02691","00568","LU0228367735.SGD","LU0588546209.SGD","LU0543330566.HKD","LU0708995583.HKD","LU0543330483.HKD","BK1561","03678","LU0979878070.USD","LU1242518931.SGD","BK1123","LU1255011170.USD","LU0315179316.USD","LU1993786604.SGD","IE00BYV24P56.USD","LU0348766576.USD","LU0469268626.HKD","LU1282648689.USD","BK1231","LU2045819591.USD","LU0051755006.USD","LU1188198961.HKD","LU0737861699.HKD","LU1813983027.USD","LU2242644610.SGD","LU1831875114.USD","LU2399975544.HKD","BK1551","IE0031814852.USD","BK1249","LU0634319403.HKD","06869","LU0348814723.USD","LU1366334578.USD","LU1807302812.USD","LU0516423091.SGD","00317","LU0516423174.USD","LU0117841782.USD","LU0106959298.USD","LU1960683339.HKD","00753","02727","LU0880133367.SGD","LU0173614495.USD","LU0862451753.SGD","LU1251922891.USD","BK1607","IE0008369823.USD","LU0326950275.SGD","IE00BZ08YS42.EUR","LU0314109678.HKD","LU0540923850.HKD","BK1523","LU1244550221.USD","01877","LU0488056044.USD","BK1183","01108","HK0001040143.USD","LU0229945570.USD","02475","83130","82846","LU0531970944.HKD","IE00BPRC5H50.USD","HK0000352382.USD","BK1105","HK0000352291.HKD","BK1574","03968","BK1554","IE00BMCWC346.EUR","IE00BVYPNP33.GBP","IE00BZ08YT58.USD","LU0502904849.HKD","IE0008368742.USD","LU0516422440.USD","LU0287142896.SGD","00553","01812","LU1961090484.USD","LU0320764599.SGD","LU1720050803.USD","SG9999014674.SGD","LU1675838814.USD","IE00B5MMRT66.SGD","BK1191","LU2226246903.HKD","LU1655091616.SGD","LU0455707207.USD","01513","IE00B29SXG58.USD","LU0918141705.HKD","SG9999001093.SGD","LU1226287529.USD","LU0431992006.USD","LU1105468828.SGD","BK1557","LU0214875030.USD","BK1163","LU0823426308.USD","LU1046422090.SGD","02338","03986","LU0572944931.SGD","EWH","LU0417516902.SGD","LU0231483743.USD","BK1125","LU0348816934.USD","LU0593848301.USD","BK1515","LU0048580855.USD","LU1719994722.HKD","BK1522","LU1481107354.HKD","LU0640798160.USD","BK1116","LU0797268264.HKD","BK1214","IE00BGHQDM52.EUR","BK1205","IE00B3M56506.USD","IE00BZ08YR35.GBP","02359","BK1122","LU0067412154.USD","LU0210526637.USD","LU0149721374.USD","LU0463099449.HKD","LU0516422366.SGD","LU1794554557.SGD","SG9999006597.SGD","02846","LU1115378108.SGD","LU1224709979.USD","LU0348825331.USD","BK1521","LU0348788117.USD","BK1564","LU0029875118.USD","LU0052750758.USD","LU0348735423.USD","03143","BK1546","BK1610","LU0348767384.USD","LU0791590937.USD","LU1282649067.USD","07233","LU0359201885.HKD","03328","SG9999004220.SGD","BK1193","BK1530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663302408","title":"Ascletis Pharma Starts Phase III Trial of Weight-Loss Drug; Shares Plummet 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663302408","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663302408?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:22","pubTimestamp":1788153761,"startTime":"0","endTime":"0","summary":"Ascletis Pharma  said the first participant has been dosed in a global Phase III clinical program for ASC30, an oral drug being developed for long-term weight management and diabetes.The program comprises two late-stage trials involving about 4,600 participants across the U.S., Europe and Canada to assess the drug's effectiveness, safety and tolerability, according to a Sunday Hong Kong bourse filing.Shares of the company plunged over 5% in Monday's trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1515","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663446024","title":"CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2663446024","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663446024?lang=en_us&edition=fundamental","pubTime":"2026-08-31 13:10","pubTimestamp":1788153044,"startTime":"0","endTime":"0","summary":"BUZZ-CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial** CanSino Biologics Hong Kong stock6185.HKleads slide in HK-listed shares of Chinese vaccine makers after news that BioNT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nL1N44S04S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4585","06185","BK1574","BNTX","BK4568","BK4139","BK1515","BK4535","688185","BK1191","BK1161","BK4548","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194450851","title":"Fed's Hawkish Signal Hits Hong Kong Drug Stocks: Innovative Medicine ETFs Slide Sharply","url":"https://stock-news.laohu8.com/highlight/detail?id=1194450851","media":"Deep News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194450851?lang=en_us&edition=fundamental","pubTime":"2026-08-31 11:26","pubTimestamp":1788146800,"startTime":"0","endTime":"0","summary":"On the final trading day of August, Hong Kong equities faced broad declines with the Hang Seng Index and Hang Seng Tech Index both dipping over 1% intraday, while the innovative drug industry chain...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","VEXC","WAMA","BK4559","VGIT","GOVT","HYGD","XLF","ZTmain","IEF","LQDD","AGG","BK4535","TYO","BIL","VFH","159137","NELS","PBDC","UPRO","ZROZ","UDN","BK1574","VCIT","SPYI","OEF","06978","TBT","LQD","SKRE","MYCN","US3Y.BOND","BWX","VOO","SPYB","FLGV","GBIL","US30Y.BOND","IAT","SHV","SPXL","LNGR","159992","159828","HIBL","SPYQ","KBWB","MINT","HK0000934320.USD","HMOP","SPXS","CIVG","ZFmain","XLRI","IEI","SPXU","TSYW","MUNX","UBT","BSV","BBIB","VGLT","US12M.BOND","US5Y.BOND","SHY","IBBQ","HYG","SCHO","BK4588","KRX",".SPX","BK1161","BK4585","SDS","TLH","FLHK","YSPY","TLTI","IGOV","SH","KRE","SMAX","DPST","US2Y.BOND","DBND","LQDU","TNmain","MMAX","US6M.BOND","ZBmain","JULD","KBE","BOXX","NEMD","BOND","IVV","SPUU","USHY","VGSH","BK4550","TBIL","TBJL","TFJL","GOLY","HYGU","SGOV","SPYU","SSO","DMAX","TLT","159316","TLTW","ESmain","XBIL","FEM","SPYM","EBUF","VCSH","SPY","LIAJ","RAUS","EMPB","BWZ","EDV","OOQB","UUP","MUB","BBSB","OEX","MEDX","SPDN","BND","TMF","BK4561","520880","MESmain","FAZ","BBLB","BK4581","ISHG","US7Y.BOND","BK4534","TIP","JPST","TLTX","US10Y.BOND","UBmain","NGHT","SPYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663228310","title":"Akeso, Inc. (HKG:9926) Analysts Are Cutting Their Estimates: Here's What You Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2663228310","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663228310?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:40","pubTimestamp":1788140412,"startTime":"0","endTime":"0","summary":"Investors in Akeso, Inc. ( HKG:9926 ) had a good week, as its shares rose 5.7% to close at HK$95.35 following the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-inc-hkg9926-analysts-are-cutting-their-estimates-heres","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-inc-hkg9926-analysts-are-cutting-their-estimates-heres","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1720050803.USD","LU0348766576.USD","IE00B543WZ88.USD","LU0348767384.USD","LU0417516738.SGD","LU1961090484.USD","LU0348735423.USD","LU2399975544.HKD","LU2476274308.USD","LU0417516571.SGD","LU0348827113.USD","IE00BPRC5H50.USD","LU2488822045.USD","LU1794554557.SGD","BK1161","KURE","09926","LU0348783233.USD","LU0634319403.HKD","LU0540923850.HKD","LU2476274720.SGD","LU0348825331.USD","LU0561508036.HKD","LU0348784397.USD","IE00B5MMRT66.SGD","LU0417516902.SGD","LU2778985437.USD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170146874","title":"Healthcare Sector Sees Continued Positive Signals; CCB Fund Manager Liang Furui Highlights High-Prosperity Areas Such as Innovative Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1170146874","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170146874?lang=en_us&edition=fundamental","pubTime":"2026-08-31 09:31","pubTimestamp":1788139881,"startTime":"0","endTime":"0","summary":"A wave of encouraging signals has recently emerged across the healthcare industry. The National Healthcare Security Administration and the National Medical Products Administration have coordinated...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK1574","IBBQ","LNGR","06978","BK1161","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663266430","title":"Zhaoke Ophthalmology (SEHK:6622) Stock Carries A 34.7x P/S Under Heavy Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2663266430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663266430?lang=en_us&edition=fundamental","pubTime":"2026-08-31 06:36","pubTimestamp":1788129366,"startTime":"0","endTime":"0","summary":"Traders kept Zhaoke Ophthalmology almost flat coming into the H1 2026 report, with the stock up only about 2% over the past week. The calm price action contrasts with a much more charged reality. The company is still posting heavy losses, with H1 basic earnings per share at a loss of ¥0.22 and a net loss of ¥122.6 million.\nThe key issue is valuation. Zhaoke Ophthalmology trades on a P/S multiple of 34.7x, compared with the Hong Kong pharmaceuticals average near 2x. This puts every line of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6622/zhaoke-ophthalmology-shares/news/zhaoke-ophthalmology-sehk6622-stock-carries-a-347x-ps-under","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6622/zhaoke-ophthalmology-shares/news/zhaoke-ophthalmology-sehk6622-stock-carries-a-347x-ps-under","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1583","BK1587","06622","BK1191","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041570","title":"Ascletis Announces First Participant Dosed in a Global Phase Iii Clinical Program of Once-Daily Oral Small Molecule Glp-1 Receptor Agonist Asc30 for Chronic Weight Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041570","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041570?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:15","pubTimestamp":1788084903,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUAB84DSR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01672","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663041506","title":"Ascletis Pharma - Topline Phase Iii Data Expected Q3 2028; FDA Nda by End 2028; Ema Maa Early 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2663041506","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663041506?lang=en_us&edition=fundamental","pubTime":"2026-08-30 18:15","pubTimestamp":1788084903,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260830:nTUAB84DSR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1515","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120832388","title":"Three New Share Subscriptions Next Week Spanning AI Chip and Innovative Drug Hotspots; Nine IPOs This Year Have Already Delivered Over 100,000 Yuan Profit Per Lot","url":"https://stock-news.laohu8.com/highlight/detail?id=1120832388","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120832388?lang=en_us&edition=fundamental","pubTime":"2026-08-30 14:30","pubTimestamp":1788071447,"startTime":"0","endTime":"0","summary":"The new share market has remained active this week. On Tuesday (August 25), Gaoke Technology made its debut on the STAR Market with an issue price of 61.36 yuan per share. The stock peaked at 262...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AIVC","BK1574","FAI","159992","MEDX","AVGU","AVGW","LNGR","AIFD","AVGC","06978","AVS","EPAI","AIS","BK1161","ALAI","IBBQ","03191","WISE","GPTZ","AVL","LRNZ","AIBU","AVGX","AVGG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":14,"pageCount":12,"totalSize":264,"code":"91000000","status":"200"}]}}